We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VMET:NASDAQVersamet Royalties Corporation Analysis

Data as of 2026-09-06 - not real-time

$10.15

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Versamet Royalties Corporation is priced at $10.15, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 12.3%. Momentum indicators put RSI at 49.4 (neutral) with MACD reading bearish. Recent trading has carved out support near $9.71 and resistance around $11.24.
On valuation the read is fair — an earnings multiple of 28.2, absent a reliable peer benchmark. Revenue is growing at 391.9% on a 49.9% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 42.9%, a beta of 1.95 and a maximum drawdown of 36.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

All amounts are in U.S. dollars unless otherwise indicated.Vancouver, British Columbia-- Newsfile Corp. - April 6, 2026...All amounts are in U.S. dollars unless otherwise indicated.Vancouver, British Columbia-- Newsfile Corp. - April 10,...All amounts are in U.S. dollars unless otherwise indicated.Vancouver, British Columbia-- Newsfile Corp. - August 13,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 10.93
  • MACD momentum is negative
  • 30-day price change of +12.3%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 10.93
  • 30-day volatility of 42.9%
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Profit margin of 49.9% is healthy
  • Revenue growth of +391.9%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth391.90%
Profit Margin49.92%
P/E Ratio28.2
ROE12.17%
ROA7.84%
Debt/Equity95.05
P/B Ratio2.9
Op. Cash Flow$49.7M
Free Cash Flow$-122397144

Technical Analysis

TrendNeutral
RSI49.4
Support$9.71
Resistance$11.24
MA 20$10.28
MA 50$10.05
MA 200$10.93
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair Value$7.70
GradeFair
TypeGrowth

Risk Assessment

Beta1.95
Volatility42.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.